These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 28583837)
1. When to Search for Occult Infection After Eradication of Hepatitis C? De Marco L; Pellicano R Gastroenterology; 2017 Jul; 153(1):327. PubMed ID: 28583837 [No Abstract] [Full Text] [Related]
2. Occult Hepatitis C Virus Infection: Are We Digging Too Deep? Koutsoudakis G; Pérez-Del-Pulgar S; Forns X Gastroenterology; 2017 Feb; 152(3):472-474. PubMed ID: 28038930 [No Abstract] [Full Text] [Related]
3. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander? Chu CJ; Lee SD J Gastroenterol Hepatol; 2010 Feb; 25(2):221-3. PubMed ID: 20136983 [No Abstract] [Full Text] [Related]
5. [Molecular diagnosis of hepatitis B virus and hepatitis C virus infection]. Nomura F; Itoga S Rinsho Byori; 2002 Nov; Suppl 123():31-6. PubMed ID: 12652787 [TBL] [Abstract][Full Text] [Related]
6. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection. Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634 [TBL] [Abstract][Full Text] [Related]
7. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection. Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection. Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959 [TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938 [TBL] [Abstract][Full Text] [Related]
10. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Bréchot C; Thiers V; Kremsdorf D; Nalpas B; Pol S; Paterlini-Bréchot P Hepatology; 2001 Jul; 34(1):194-203. PubMed ID: 11431751 [No Abstract] [Full Text] [Related]
12. Drug-resistant viral hepatitis. Wright M; Main J; Thomas HC J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634 [No Abstract] [Full Text] [Related]
13. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete. Drositis I; Bertsias A; Lionis C; Kouroumalis E Eur J Intern Med; 2013 Dec; 24(8):839-45. PubMed ID: 23988264 [TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ; J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912 [TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Song EY; Yun YM; Park MH; Seo DH Intervirology; 2009; 52(2):57-62. PubMed ID: 19401629 [TBL] [Abstract][Full Text] [Related]
18. [Progress on diagnosis and therapy of hepatitis, A, hepatitis B and hepatitis C]. Suzuki S Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):987-91. PubMed ID: 2172427 [No Abstract] [Full Text] [Related]
19. Interference of replication between hepatitis B and C viruses in patients infected with HIV. Yang RR; Gui X; Chen XY; Zhu Y J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419 [TBL] [Abstract][Full Text] [Related]
20. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses. De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]